Molecular medicine: Predicting and preventing Huntington's disease

Neurological Sciences

Volumn 29, Issue 4, 2008, Pages 205-207

  Squitieri, Ferdinando ^a   Cannella, Milena ^a   Frati, Luigi ^b  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CREATINE; CYTOSINE; GENE PRODUCT; GUANINE; HUNTINGTON DISEASE PROTEIN; NEUROPROTECTIVE AGENT; RILUZOLE; UNCLASSIFIED DRUG;

CHROMOSOME 4P; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFICACY; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SCREENING; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; MOLECULAR GENETICS; MORTALITY; MUTATIONAL ANALYSIS; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREDICTION; RISK ASSESSMENT; SHORT SURVEY; STANDARDIZATION; SYMPTOM;

AGE OF ONSET; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; HUNTINGTON DISEASE; MOLECULAR BIOLOGY; PREDICTIVE VALUE OF TESTS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 53149096994     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-0969-3     Document Type: Short Survey

References (17)

1. Vonsattel JP, Myers RH, Stevens TJ et al (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577
2. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983
3. Gellera C, Meoni C, Castellotti B et al (1996) Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene. Am J Hum Genet 59:475-477
4. Squitieri F, Campanella G, Hayden MR (1996) Update on genetics of Huntington's disease: Availability of direct and accurate predictive test. Ital J Neurol Sci 17:185-187
5. Squitieri F, Berardelli A, Nargi E et al (2000) Atypical movement disorders in the early stages of Huntington's disease: Clinical and genetic analysis. Clin Genet 58:50-56
6. Squitieri F, Sabbadini G, Mandich P et al (2000) Family and molecular data for a fine analysis of age at onset in Huntington disease Am J Med Genet 95:366-373
7. Penney JB Jr, Young AB, Shoulson I et al (1990) Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 5:93-99
8. Kassubek J, Juengling FD, Kioschies T et al (2004) Topography of cerebral atrophy in early Huntington's disease: A voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 75:213-220
9. Ciarmiello A, Cannella M, Lastoria S et al (2006) Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med 47:215-222
10. Henley SM, Frost C, MacManus DG et al (2006) Increased rate of whole-brain atrophy over 6 months in early Huntington disease. Neurology 67:694-696
11. Rosas HD, Salat DH, Lee SY et al (2008) Cerebral cortex and the clinical expression of Huntington's disease: Complexity and heterogeneity. Brain 131:1057-1068
12. Borovecki F, Lovrecic L, Zhou J et al (2005) Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci U S A 102:11023-11028
13. Douaud G, Gaura V, Ribeiro MJ et al (2006) Distribution of grey matter atrophy in Huntington's disease patients: A combined ROI-based and voxel-based morphometric study. Neuroimage 32:1562-1575
14. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787-795
15. Hersch SM, Gevorkian S, Marder K et al (2006) Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology 66:250-252
16. Squitieri F, Ciammola A, Colonnese C, Ciarmiello A (2008) Neuroprotective effects of riluzole in Huntington's disease. Eur J Nucl Med Mol Imaging 35:221-222
17. Cannella M, Simonelli M, D'Alessio C et al (2001) Presymptomatic tests in Huntington's disease and dominant ataxias. Neurol Sci 22:55-56